Thursday, February 16, 2017 12:39:21 PM
In the link below Vanessa Luna introduces Dan De Liege after her opening
remarks:
Shareholder’s Call
September 23, 2015
http://www.alliancebioe.com/
Who is Vanessa Luna?
Public Relations and Media Contact:
LCG
Headquarter Office
702.333.4886
www.lcginfo.com
http://tinyurl.com/hpmacmn
LCG Info - Vanessa Luna:
LCG
Vanessa Luna
702-761-6967
http://tinyurl.com/zs3lh39
And Jens? He was doing ALLM's PR before Vanessa's
company:
<<August 18, 2014:
EraStar, Inc. Appoints Mr. Jens Dalsgaard as Chairman of the Board and Co-CEO>>
http://finance.yahoo.com/news/erastar-inc-appoints-mr-jens-150500500.html
EraStar, Inc
(775)771-5808
http://tinyurl.com/zwzugop
EraStar got warrants at one point but they were cancelled:
<<During the fiscal year ended December 31, 2014, the Company entered into a common stock purchase warrant agreement with EraStar, Inc. whereby it issued a warrant to purchase 500,000 shares of Common Stock for a period of five (5) years at an exercise price of $1.00 per share. Using a Black-Scholes asset pricing model, this agreement was valued at $278,850 and was being amortized over the life of the agreement. In April 2015, the Company received notice that EraStar, Inc. terminated this agreement and returned 100,000 shares of Company common stock for cancellation and also forfeited the warrant agreement to purchase 500,000 shares of common stock, which has a remaining value of (255,612).>>
http://www.secinfo.com/d14qfp.w595.m.htm
Recent BIOF News
- Form 8-K - Current report • Edgar (US Regulatory) • 01/24/2024 02:34:54 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 05:41:18 PM
- Form D/A - Notice of Exempt Offering of Securities: [Amend] • Edgar (US Regulatory) • 08/17/2023 01:26:03 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/07/2023 05:43:21 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM